Product Images Tadalafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Tadalafil NDC 70934-473 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
70934 473 06 Master Bottle Label Approval Rev A 12 19
This is a medication information about Tadalafil tablets, with National Drug Code (NDC) 70934-473-06. No further information is available from the text.*
84125597 9492 4bb8 bbba 6d56a874e856 01
84125597 9492 4bb8 bbba 6d56a874e856 02
84125597 9492 4bb8 bbba 6d56a874e856 03
84125597 9492 4bb8 bbba 6d56a874e856 04
84125597 9492 4bb8 bbba 6d56a874e856 05
84125597 9492 4bb8 bbba 6d56a874e856 06
Not available.*
84125597 9492 4bb8 bbba 6d56a874e856 07
The text provides information about the change from baseline in IPSS total score after treatment with Tadalafil 5mg as compared to Placebo. The results show that the change is statistically significant (p<0.01) with Tadalafil 5mg being more effective in reducing IPSS total score than placebo. The duration of treatment in weeks is not available.*
84125597 9492 4bb8 bbba 6d56a874e856 08
84125597 9492 4bb8 bbba 6d56a874e856 09
This text describes a graph or chart that displays the change in IPSS (International Prostate Symptom Score) total score over a 12-week treatment period. The treatment options compared are Tadalafil 5mg and Placebo. The asterisk indicates that there is a statistically significant difference between Tadalafil and Placebo.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.